
Am J Psychiatry 159:1876-1881, November 2002
© 2002 American Psychiatric Association
Effects of Metergoline on Symptoms in Women With Premenstrual Dysphoric Disorder
Catherine A. Roca, M.D.,
Peter J. Schmidt, M.D.,
Mark J. Smith, M.D., Ph.D.,
Merry A. Danaceau, R.N.,
Dennis L. Murphy, M.D., and
David R. Rubinow, M.D.
OBJECTIVE: The authors investigated the role of acute serotonergic modulation in the efficacy of selective serotonin reuptake inhibitors (SSRIs) in women with premenstrual dysphoric disorder. METHOD: Patients with premenstrual dysphoric disorder (whose symptoms had remitted during treatment with fluoxetine) and a group of unmedicated healthy comparison women received the serotonin receptor antagonist metergoline as part of a double-blind, placebo-controlled crossover study. RESULTS: The patients with premenstrual dysphoric disorder experienced a return of symptoms 24 hours after treatment with metergoline but not diphenhydramine (active placebo). The comparison women experienced no changes in mood. CONCLUSIONS: These data support the role of altered serotonergic transmission in the efficacy of SSRI treatment for premenstrual dysphoric disorder.
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Henshaw
PMS: diagnosis, aetiology, assessment and management: REVISITING... PREMENSTRUAL SYNDROME
Advan. Psychiatr. Treat.,
March 1, 2007;
13(2):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. W. Freeman, K. Rickels, S. J. Sondheimer, M. Polansky, and S. Xiao
Continuous or Intermittent Dosing With Sertraline for Patients With Severe Premenstrual Syndrome or Premenstrual Dysphoric Disorder
Am J Psychiatry,
February 1, 2004;
161(2):
343 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|